Market Overview

Why Monopar's Stock Is Trading Higher Today

Share:
Why Monopar's Stock Is Trading Higher Today

Monopar Therapeutics (NASDAQ: MNPR) shares are trading higher on Tuesday, after the company announced it joined forces with NorthStar to develop a radio-immuno-therapeutics to target severe coronavirus.

Monopar Therapeutics is a U.S.-based clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to improve clinical outcomes for cancer patients. Its pipeline products comprise of Validive, Camsirubicin, and MNPR-101.

Monopar Therapeutics shares were trading up 11.64% at $9.21 at the time of publication on Tuesday. The stock has a 52-week high of $48 and a 52-week low of $4.94.

 

Related Articles (MNPR)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com